Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |